Merck & Co's cancer drug Keytruda has been granted a priority review so that the immunotherapy medicine can be used in conjunction with chemotherapy to improve survival rates for untrea
The NHS has announced a review to investigate the training needs of NHS staff, so they have the skills to administer groundbreaking artificial intelligence and robotics-based treatments.
